Skip to main content
logo
Alembic Pharmaceuticals Limited (BOM:533573)
India flag India · Delayed Price · Currency is INR
1,031.20
-2.95 (-0.29%)
At close: Jul 18, 2025

Alembic Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Alembic Pharmaceuticals had annual revenue of 66.72B INR with 7.12% growth. Alembic Pharmaceuticals had revenue of 17.70B in the quarter ending March 31, 2025, with 16.65% growth.

Revenue
66.72B
Revenue Growth
+7.12%
P/S Ratio
3.04
Revenue / Employee
4.03M
Employees
16,571
Market Cap
202.74B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202566.72B4.43B7.12%
Mar 31, 202462.29B5.76B10.19%
Mar 31, 202356.53B3.47B6.54%
Mar 31, 202253.06B-873.40M-1.62%
Mar 31, 202153.93B7.87B17.10%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Reliance Industries9,882.72B
HDFC Bank2,728.47B
Tata Consultancy Services2,561.48B
Bharti Airtel1,729.85B
ICICI Bank2,006.54B
State Bank of India3,429.39B
Infosys1,647.16B
Hindustan Unilever631.21B
Revenue Rankings

Alembic Pharmaceuticals News

More News